-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Neumora Therapeutics, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
- Neumora Therapeutics, Inc. General and Administrative Expense for the quarter ending 30 Sep 2025 was $12,180,000, a 24% decline year-over-year.
- Neumora Therapeutics, Inc. General and Administrative Expense for the twelve months ending 30 Sep 2025 was $63,291,000, a 12% increase year-over-year.
- Neumora Therapeutics, Inc. annual General and Administrative Expense for 2024 was $62,537,000, a 38% increase from 2023.
- Neumora Therapeutics, Inc. annual General and Administrative Expense for 2023 was $45,475,000, a 46% increase from 2022.